Navigation Links
Outreach Nations Stand United on Climate Change

The outreach nations-- India, Brazil, China, South Africa and Mexico-- which form 42 per cent of the worlds population, will present a united front on the issue of climate change at Baltic resort in Heilingdam today before the G-8 leaders.

In a joint statement released after a high-level meeting of the outreach nations, Lula da Silva of Brazil, Chinese President Hu Jintao, Indian Prime Minister Manmohan Singh, Mexican President Felipe Calderon, and Thabo Mobiki of South Africa reaffirmed their shared conviction that developing countries must participate more actively in the consolidation of strategies and initiatives that effectively address the challenges of a globalising and increasingly interdependent world.

Further cementing the cooperation, Indian Prime Minister Manmohan Singh sent a strong signal by stating that developing countries must be treated as partners and not petitioners in the changed global scenario, especially while dealing with key geopolitical issues.

The O5, or the outreach countries, also discussed how the five countries could push South-South cooperation in various issues of global importance.

Climate change, the Doha Development Round of global trade talks and inclusive growth were among the issues discussed by the five leaders, Indian Foreign Secretary Shivshankar Menon told reporters after the meeting.

However, the G8 countries have reached a compromise and there is a breakthrough deal among these countries according to which they have agreed to slash greenhouse gas emissions by 50 percent by 2050, compared to 1990 levels.

But the members are resolute that they cannot hinder their development at the cost of emission cuts and these countries continue to blame the developed world for the increasing pollution.


'"/>




Page: 1

Related medicine news :

1. Telephone Outreach Boost CRC Screening In Urban Minority
2. Asian Nations Told To Ready Themselves For Pandemic
3. Asian Nations To Take Joint Efforts Against H5N1
4. Donor Nations Urged To Pledge More To Combat Bird Flu
5. Joint Effort among Various Nations to Tackle Bird Flu
6. Developing Nations Should Reform Health Financing Systems: WB
7. 2010 AIDS Target May Misfire, Warns United Nations
8. AIDS Meet Ends Without Firm Commitments From Donors Dharam Shourie United Nations
9. United Nations draws flak Due to Lukewarm AIDS Prevention Measures
10. Vaccines For Cervical Cancer Will Soon Be Available In Developing Nations
11. Developing Nations to Get Gardasil at Lesser Rates from Merck Soon
Post Your Comments:
(Date:10/7/2008)...-USNewswire/ -- As the presidential,candidates com...ate, Jean,Berg, a nursing assistant and member of ...waiting to ask John McCain why he wants to tax hea...o afford coverage., Berg has been a nursing assis...are., "It,s the single biggest economic factor in...
(Date:10/7/2008)...umors easier to spot , , TUESDAY, Oct. 7...t one type of breast cancer in women with an evalu...ors make an earlier diagnosis of another form of b... previously had been shown to reduce the risk of e...men at high risk of the disease, but not to affect...
(Date:10/7/2008)...ffect in post-HAART era , , TUESDAY, Oct... research finds little evidence that circumcision ...s, but the issue is still far from settled. , F...f powerful AIDS drugs showed that circumcision did... launched the most definitive type of research int...
(Date:10/7/2008)... Center at the University of California, San Diego...lentless march of advanced lung cancer by treating...le many vaccines attempt to pump up the immune sys...x, is genetically engineered to also trick the can... activities. , The first patients have begun enr...
Breaking Medicine News(10 mins):Health News:SEIU Member Will Be in Town Hall Audience, Ready to Ask John McCain Why He Won't Provide Affordable Healthcare for All 2Health News:Tamoxifen Speeds Diagnosis of ER-Negative Breast Cancer 2Health News:Role of Circumcision in Reducing HIV Risk Still Unclear 2Health News:Novel Lung Cancer Vaccine Trial Launched at Moores UCSD Cancer Center 2
...l toxins in corn may be the reason for neural tube...the early 1990's. The study published in the on ...gests that corn and its products //that have been ...ht give rise to neural tube defects (NTD), if cons...
...ng is reportedly being prohibited on the grounds o...on a vacation at Utah. The British Medical Journal...second hand smoke (SHS) does not raise the risk //... the measures as attempts by the powerful antismok...
...h officials in Argentina have reported an outbreak...der close to Paraguay. More than 70 cattle have be... province, //according to reports by National Serv... origin of the outbreak is yet to be identified an...
...an Letter, a male nurse aged 27, has admitted to k...hat nothing of what he says could actually justify...eat compassion to alleviate their pain.// He was ...urders to manslaughter, to reduce the penalty. The...
Other Medicine News:Health News:Fungal toxins infected corn the reason for congenital defects 2
(Date:10/7/2008)...of FLEXX Trial Presented at the Osteoarthritis Res... PARSIPPANY, N.J., Oct. 7 /- Ferring...rom the FLEXX Trial of Osteoarthritis of the,Knee,... a highly pure,non-avian high molecular weight for...uperior to intra-articular saline (IA-saline) for ...
(Date:10/7/2008)...nical study of adults, VYVANSE taken once-daily si...ne week, PHILADELPHIA, Oct. 7 /PRNewswire-FirstCa...obal specialty biopharmaceutical company, today,an...sue of the Journal of,Clinical Psychiatry found on...Deficit Hyperactivity Disorder (ADHD) symptoms in ...
(Date:10/7/2008)..., Calif., Oct. 7 /- Aerovance Inc. to...from a Phase I trial of its Aerovant,inhalation po...idence of,local irritancy following asthma patient... dose will be the highest of three doses investiga...hich is scheduled to begin early,next year. Eviden...
(Date:10/7/2008)...5 Patient Cohort Enrolled in Stage A of Trial Asse...h Carboplatin and Paclitaxel -, TUSTIN, Calif., O...uticals, Inc. (Nasdaq: PPHM ), a clinical stage b...ibodies for the treatment of cancer and,hepatitis ...as completed,enrollment in the first stage of a Ph...
Breaking Medicine Technology:Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 5Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 6Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 3Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 4Young Pop Stars Emphysema Startles Experts 22570 1Young Pop Stars Emphysema Startles Experts 22570 2Young Pop Stars Emphysema Startles Experts 22570 3Studies Show USGI Medicals EndoSurgical Operating System 28TM 29 Enables Incisionless Surgery to Reduce Gastric Pouch and Stoma After Gastric Bypass 6162 1Studies Show USGI Medicals EndoSurgical Operating System 28TM 29 Enables Incisionless Surgery to Reduce Gastric Pouch and Stoma After Gastric Bypass 6162 2Arterial Calcium Scans Can Predict Death Risk 22563 1Arterial Calcium Scans Can Predict Death Risk 22563 2Arterial Calcium Scans Can Predict Death Risk 22563 3Arterial Calcium Scans Can Predict Death Risk 22563 4Advertising Hall of Famer Charles D Peebler Receives Honor for Work Supporting Cure for Progressive Supernuclear Palsy 22559 1Advertising Hall of Famer Charles D Peebler Receives Honor for Work Supporting Cure for Progressive Supernuclear Palsy 22559 2
...LOS ANGELES--(BUSINESS WIRE)--Apr 16, 2007 - Intro...ted ADVEXIN(R) biomarker data over,the weekend in ...he,American Association for Cancer Research., Abno...most,common and fundamental molecular defects in c...o restoring p53 tumor suppressor,function and the ...
...- As previously announced, primary endpoint not me...t-study treatment with ERBITUX,-, NEW YORK, April ... Incorporated and Bristol-Myers Squibb Company tod...- a randomized,open-label, multi-center Phase III...notecan to irinotecan alone in patients with,metas...
Other Medicine Technology:Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference 2Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference 3Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference 4Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 2Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 3Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 4Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 5Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 6Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 7Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 8Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 9
The DLP Elongated One-Piece Arterial Cannulae features a longer body for easier access during conventional and minimally invasive procedures
The Select Series® Arterial Cannulae utilize a state-of-the-art dip-molding technology. This process allows molding of a one-piece, wire-wound cannula that is flexible and kink-resistant.
Intermittent catheter
Intermittent catheter
Medicine Products: